Transcript Presentation Titles Are Verdana 30pt, Regular

Regional Cooperation to
Improve Access to
Medicines
Thursday, October 30, 2014
Artwork by Sebastian Ferreira
Mark Fleming
Director, Federal Affairs & Health Policy
One company making a difference for patients everyday
Janssen is proud to feature artwork created by people affected
by the illnesses and diseases we are committed to treating and preventing.
Objectives:
1. Improving access to innovative medicines
in Atlantic Canada means improving
outcomes for patients
2. Medicines are a contributor to health
system sustainability, not a barrier
3. Harnessing the power of partnership and
collaboration to deliver better health
outcomes
Regional Cooperation to Improve Access to Medicines
7/17/2015
2
A Flawed Premise:
• A silo approach focused to
containing drug costs
misses the mark
• Where the evidence exists
perhaps more should be
invested in medicines
where clear downstream
offsets in the health system
or society can be realized
• Medicines are ~ 8.5% of
publicly funded health care
costs
Source: CIHI, National Health Expenditure Trends, 1975-2013
https://secure.cihi.ca/estore/productFamily.htm?locale=en&pf=PFC2400
Regional Cooperation to Improve Access to Medicines
7/17/2015
3
Living Examples
Regional Cooperation to Improve Access to Medicines
7/17/2015
4
Vaccines:
• Evidence is clear on the benefits of
vaccinations to the health system
and society
• Reduced hospitalization, morbidity,
mortality
• It would be easy to “cost-contain”
vaccines but the impact would be
devastating
Regional Cooperation to Improve Access to Medicines
7/17/2015
5
Vaccines: 2013-14 Flu Season
Region
Total Vaccine
Ordered
%age of
population
covered
Total vaccine
doses delivered
by pharmacists
Vaccine doses
delivered by
pharmacists as
%age of total
NS
435,000
46%
60,000
14%
NB
260,000
34%
30,000
12%
ON
4,400,000
33%
650,000
15%
AB
1,100,000
27%
334,000
30%
BC
1,400,000
31%
Est. 400,000
29%
CANADA
10,400,000
30%
1,455,000
19%
• The power of partnership – leveraging expanding pharmacist scope
of practice to enhance vaccine uptake
• This flu season, 8 of 10 provinces will have pharmacist scope of
practice for vaccines in place (+MB, +PEI, +NF)
Source: October 3, 2014 presentation by Shoppers Drug Mart
to the Vaccine Industry Committee, Saskatoon, Sask.
Regional Cooperation to Improve Access to Medicines
7/17/2015
6
Collaborative Success
Alberta Influenza Immunizations
including FluMist
2013-2014
2012-2013
2011-2012
Physicians
129,121
115,148
72,884
Pharmacists
334,418
170,733
89,324
557,978
503,904
514,688
1,157,550
919,348
874,000
Alberta Health
Services
Total
Increased vaccination of 44,000 Albertans in 2012-13 vs. 2011-12
Increased vaccination of 238,000 Albertans in 2013-14 vs. 2012-13; 174,000 by pharmacists
Source: October 3, 2014 presentation by Shoppers Drug Mart
to the Vaccine Industry Committee, Saskatoon, Sask.
Regional Cooperation to Improve Access to Medicines
7/17/2015
7
Innovation Driving Outcomes
• People living with
schizophrenia and
medication adherence
issues
• Real world evidence study
at William Osler (Ontario)
• 6-fold reduction in ER
visits, 32 fewer days in
hospital per patient per
year
• System savings of $17K
per patient per year
Source: Koczerginski D, Arshoff L
William Osler Health System, in Brampton, ON
[2011, 14(1):82-87]
Regional Cooperation to Improve Access to Medicines
7/17/2015
8
Power of Partnership
Regional Cooperation to Improve Access to Medicines
7/17/2015
9
Value Demonstrating Initiatives:
• Bringing industry,
government, academia,
health care professionals and
patients to the table
• Focus on improving patient
outcomes cost-effectively
ACROSS the health care
system
Breaking down silos and creating powerful partnerships
for better health outcomes
• Real world evaluation of
health care and societal
impact of innovative health
technologies
Regional Cooperation to Improve Access to Medicines
7/17/2015
10
NB Diabetes Clinical Order Sets
(DCOS)
• Focus: Improving glycemic
management and outcomes for
hospitalized diabetes patients
• Partners:
–
–
–
–
–
Vitalité Health Network
Horizon Health Network
New Brunswick Department of Health
Rx&D/Rx&D Health Research Foundation
5 member companies
• Desired Outcomes:
– Enhanced glycemic control
– Reduced patient risk
– Shorter hospital stays
Source: July 14, 2014, Research project will improve care for hospitalized patients with diabetes
http://www2.gnb.ca/content/gnb/en/news/news_release.2014.07.0862.html
Regional Cooperation to Improve Access to Medicines
7/17/2015
11
NB Drug Program Partnership
• Focus: Measure the impact of the
government of New Brunswick’s
Catastrophic Drug Coverage Program
• Partners:
– New Brunswick Health Research Foundation
– New Brunswick Department of Health
– Rx&D Health Research Foundation
• Desired Outcomes:
– Measured impact of the program
– Hospital visits, length of stay
– Impact on patients and the health care system
Source: Partnership to study impact of New Brunswick Drug Program
http://www.hrf-frs.com/News.asp?a=view&id=132
Regional Cooperation to Improve Access to Medicines
7/17/2015
12
PEI COPD Project
(completed 2011)
• Focus: Improving qualify of care,
access, efficiency and patient selfmanagement of COPD
• Partners:
–
–
–
–
Harbourside Family Health Centre
PEI Lung Association
Government of PEI
Rx&D Member Companies
• Delivered Outcomes:
–
–
–
–
50% decrease in ER visits
30% reduction in return visits to ER
Average length of hospital stay  1 day
Expanded across PEI in 2012
Source: Health PEI, Vol. 1, No. 1, Chronic Obstructive Pulmonary Disease
http://www.gov.pe.ca/photos/original/hpei_cdpm_b1.1.pdf
Regional Cooperation to Improve Access to Medicines
7/17/2015
13
Regional Collaboration
Regional Cooperation to Improve Access to Medicines
7/17/2015
14
An Opportunity for Atlantic Canada
• Medicines reviewed/recommended by
CDR and negotiated through PCPA
are, by definition added value to the
health care system
• Rapid and simultaneous access to
these innovations across all four
provinces
• Open the doors for public/private
partnerships focused on cost-effective
outcomes for patients
Regional Cooperation to Improve Access to Medicines
7/17/2015
15
Thank You!
Mark Fleming, Janssen Inc. Canada
[email protected]